Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Neumann

Showing results (261-270 of 267) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 267 results.
Annals of the Rheumatic Diseases|July 3, 2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroupsGonzalo Borrego-Yaniz, Vera Fuentes-Moreno, Lourdes Ortiz-Fernández, et al.
ALTEX|March 1, 2020
Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug developmentUwe Marx, Takafumi Akabane, Tommy B Andersson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
The Lancet. Rheumatology|May 11, 2024
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association studyGonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, et al.
American Journal of Human Genetics|January 3, 2017
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell ArteritisF David Carmona, Augusto Vaglio, Sarah L Mackie, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
European Heart Journal|April 16, 2023
A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF studyRoland Richard Tilz, Vanessa Schmidt, Helmut Pürerfellner, et al.
Pageof 27

Showing results (261-270 of 267) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 267 results.
Annals of the Rheumatic Diseases|July 3, 2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroupsGonzalo Borrego-Yaniz, Vera Fuentes-Moreno, Lourdes Ortiz-Fernández, et al.
ALTEX|March 1, 2020
Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug developmentUwe Marx, Takafumi Akabane, Tommy B Andersson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
The Lancet. Rheumatology|May 11, 2024
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association studyGonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, et al.
American Journal of Human Genetics|January 3, 2017
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell ArteritisF David Carmona, Augusto Vaglio, Sarah L Mackie, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
European Heart Journal|April 16, 2023
A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF studyRoland Richard Tilz, Vanessa Schmidt, Helmut Pürerfellner, et al.
Pageof 27